caption: a line of line of treatment for bc - cell deletition with belmuab in patients with sl
exif: {"Image DocumentName": "B-Cell Depletion With Belimumab in Patients With SLE", "Image ImageDescription": "Biomarkers. Changes correlated with clinical improvement observed over 2.5 years of belimumab treatment: \uf0ad in C3 and C4 levels. \uf0af in anti-dsDNA antibody levels. \uf0af in IgG, IgM, and IgE levels (more in subjects with elevated levels at baseline) Reversion of anti-Sm and anti-RNP serologic findings from positive to negative in some belimumab-treated subjects. See hard copy abstracts. Stohl W et al. Arthritis Rheum. 2007;56(9 suppl):S210 [abstract 426]. 89.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}